Catheter-Related Thrombosis A Catalyst of Complications
|
|
- Phillip May
- 6 years ago
- Views:
Transcription
1 Catheter-Related Thrombosis A Catalyst of Complications
2 Catheter-Related Occlusions 1,2 Most common non-infectious complication in the long-term use of CVCs, and in particular PICCs Approximately 1 in 4 CVCs may become occluded 3 types of Occlusions: Biological Mechanical Physical 2
3 Economics of Thrombotic Occlusions 3,4 Cost of ER visit or readmit Cost of Catheter Exchange RN $35-50/hour TPA $120/dose What is the cost of inefficient delivery of IV therapy? * Based on anecdotal reports Fall
4 Tissue Plasminogen Activator (TPA) 5,6 3,723 patients with PICCs 40% received TPA The adjusted odds of developing CLA-BSI 3.59 times greater in those patients that received TPA compared with those who did not There is a positive correlation between the use of alteplase for malfunctioning catheters and the development of CLABSI 6 4
5 VTE, DVT, UEDVT 7 VTE = Venous ThromboEmbolism A condition that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT = Deep Vein Thrombosis The formation of a blood clot in a deep vessel. The deep veins follow the course of the arteries. They are generally arranged in pairs, and are situated on either side of the artery, and connected at intervals by short transverse branches UEDVT = Upper Extremity Deep Vein Thrombosis Deep vein thrombosis occurring in the upper extremities 5
6 Incidence Rates 8,9-15 Symptomatic PICC related DVTs = 3-20% incidence 72% Rate of Asymptomatic PICC Related DVTs and thrombosis Asymptomatic + symptomatic PICC related DVTs = % incidence Median time to thrombus: 8 to 12 days Financial impact of one DVT = Avg. $10,000- $15, % Rate of Symptomatic PICC Related DVTs 6
7 UEDVT Risk Factors 16 History of DVT History of venous thrombosis was the strongest risk factor for developing a PICCrelated thrombosis Catheter tip placement Correct positioning significantly lowered the risk of catheter-related thrombosis Non-central PICC tip location was associated with a 2.34-fold higher risk of thrombosis development Infection Catheter-related thrombosis and infection are significantly correlated in multiple studies Cancer The presence of cancer and a CVC increase the risk of UEDVT 18-fold Hypertension (HTN) 70% of patients who developed UEDVT had a history of HTN 7
8 UE-DVT Risk Factors 16 Infection Cancer Osteomyelitis Obesity HTN Diabetes History of DVT Use of anticoagulants Insertion attempts Catheter tip location Size of the catheter Vein selection Solution infused Provider who places the PICC Major surgery Pregnancy Contraception Hormone replacement therapy Age Gender Smoking Immobility 8
9 The 3 P s of CRT 16,17 Patient Cancer Previous DVT Hypertension Provider Tip termination location Catheter: Vein ratio Determination of necessity PICC Diameter # of lumens Anti-thrombogenic technology 9
10 Link Between Infection & Thrombosis 18 Infection is linked to thrombosis Post-mortem evaluation of 72 cancer patients with CVCs showed a strong correlation between CR-sepsis and CVC thrombosis Fibrin layer present on ALL catheters CR-Thrombosis present in 38% of cases** 23% of these had sepsis** All patients with sepsis had thrombosis 10
11 Patients With Cancer 19 Patients with cancer are at high risk for developing venous thromboembolism (VTE) due to disease state & treatment factors The presence of a central venous catheter (CVC) further increases this risk Thrombosis and Infection are serious complications and more common in patients with cancer There is a 47-fold increase in the risk of mortality from VTE in cancer patients with a CVC 11
12 Deep Vein Thrombosis Awareness Each year as many as 1.2 Million Americans suffer from Venous Thromboembolism (VTE), which includes Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) (CDC) At least 120,000 deaths per year are directly related to VTE It is among the top 5 causes of death in the US VTE is the leading cause of preventable, in-hospital deaths affecting more people annually than highway fatalities, breast cancer and AIDS combined 74% of people surveyed have little or no awareness of DVT symptoms Cost to treat (mean) $9,247/patient/year 12
13 Impact of PICC-Related DVT 22 Interrupts treatment Increased LOS Increases cost Morbidity Risk of Mortality 13
14 Healthy People Surgeon General s Call to Action About 10 percent of people with DVT die from pulmonary embolism making DVT the most common preventable cause of death in hospitals persons per 10,000 population aged 18 and older developed VTE in 2007 TARGET: 48.9 per 10,000 10% 14
15 DATA Collect It Understand It Use It to improve your practice! Use it to improve your outcomes! 15
16 References 1. Bartock, L. (July 2010) Evidence-based Systematic Review of Literature for the Reduction of PICC Line Occlusions. Journal of the Association for Vascular Access. 15(2) Hadaway, L. (2005) Reopen the Pipeline. Nursing. pp Haire WD & Herbst SF. (Summer 2000). Consensus conference on the use of alteplase (TPA) for the management of thrombotic catheter dysfunction. Journal of Vascular Devices. 4. Palatnik, A. (2001). Cathflo Activase (alteplase) FDA-approved fibrinolytic indicated in the treatment of CVAD occlusions. Retrieved November 10, 2014 at 5. Thakarr, K., Collins, M., Kwong, L., Sulis, C., Korn, C., Bhadelia, N. (2014) The role of tissue plasminogen activator use and systemic hypercoaguablity in central line associated blood stream infections. American Journal of Infection Control. 42: Rowan et al. (2013). Alteplase use for malfunctioning central venous catheters correlates with catheter assoicated blood stream infections. Pediatric Critical Care Medicine. 7. John Hopkins Medicine. (2014). Deep vein thrombosis. accessed September Journeycake, J. & Buchanan, G. (2003). Thrombotic complications of CVC in Children. Current Opinion in Hematology. 10: Itkin, M., Mondshein, J., Stavropoulos, W., Shlanski-Goldberg, R., Sallen, M., Trerobla, S. (2013). Peripherally inserted central catheter thrombosis reverse taper vs. nontapered catheters: A randomized controlled study. Journal of Vascular Interventional Radiology. Doi: org/ /j.jvir Evans, RS, Sharp, JH, Linford, LH, et al. (2010). Risk of symptomatic DVT associated with peripherally inserted central catheters. CHEST. 138: Tran, H, Arellano, M., Chamsuddin, A, et al. (2010). Deep vein thrombosis in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymph. 51: Trerotola SO, Stavropoulos SW, Mondschein JI, et al. (2010). Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology. 256: Lobo, BL, Vaidean, G., Broyles, J., Reaves, AB, Shorr, RI. (2009). Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 4: Nash, EF, Helm, EJ, Stephenson, A, Tullis, E. (2009). Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J Vasc Interv Radiol. 20: Paauw, JD, Border, H., Ingalls, N. et al. (2008). The incidence of deep vein thrombosis associated with peripherally inserted central catheters in thrombosis with and without the use of prophylactice anti-coagulants. JPEN. 32: Clemence, B. & Maneval, R. (2014). Risk factors associated with catheter-related upper extremity deep vein thrombosis in patients with peripherally inserted central catheters: Literature Review: Part 1. Journal of Infusion Nurses Society. 37(3):
17 References (con t) 17. Trerotola, S., & V. Chopra, (September, 2014). Venous thrombosis: The elephant in the room for PICCs. Presented at the Association for Vascular Access National Scientific Meeting, National Harbor, MD. Slide Raad, I., Luna, M., Kahil, S., Costerton, J., Lam., C., Bodey, G. (1994). The relationship between the thrombotic and infectious complications of CVC. JAMA. 271(13). 19. Khorana, AA, et al (2007). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Journal Thromb Haemost. 20. Kutcher, N. (2011). Deep vein thrombosis of the upper extremities. The New England Journal of Medicine. 364(9): Healthy People Blood disorders and blood safety. Accessed September Khorana et al., (2013). Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States.Clin Econ Outcomes Res.5:
Reaching New Heights in Understanding Central Venous Catheter Thrombosis
Reaching New Heights in Understanding Central Venous Catheter Thrombosis Lynn Manly, RN, CRNI, VA BC, Clinical Director, Navilyst Medical, Tarpon Springs, FL Top 4 Things to Know for CE 1. Make sure your
More informationReaching New Heights in Understanding Central Venous Catheter Thrombosis
Reaching New Heights in Understanding Central Venous Catheter Thrombosis Lynn Manly, RN, CRNI, VA BC, Clinical Director, Navilyst Medical, Tarpon Springs, FL Top 4 Things to Know for CE 1. Make sure your
More informationRESTORING PATENCY TO CENTRAL VENOUS ACCESS DEVICES
RESTORING PATENCY TO CENTRAL VENOUS ACCESS DEVICES Indications Venous access is poor Intravenous therapy involves venous sclerosants Ambulatory chemotherapy given as an outpatient Repeated sampling, or
More informationPrevention of thrombosis
Prevention of thrombosis Massimo Lamperti MD, MBA Chief of General Anaesthesia Department Anaesthesiology Institute Cleveland Clinic Abu Dhabi Clinical Professor of Anaesthesiology Cleveland Clinic Lerner
More informationNuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?!
Nuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?! Massimo Lamperti MD, MBA! Clinical Professor of Anesthesiology! Cleveland Clinic Lerner College of Medicine! Chief of General
More informationReducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio
Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio Timothy R. Spencer, DipAppSc, BHSc, ICCert, RN, APRN, VA-BC Disclosures Director, Global Vascular Access,
More informationCatheter Vessel Ratio : Now What?
Catheter Vessel Ratio : Now What? Timothy R Spencer, DipAppSc, BHealth, IC Cert, RN, APN, VA-BCTM Keegan J Mahoney, BS, RRT, VA-BCTM Vascular Access Specialist, Global Vascular Access, Scottsdale AZ Vascular
More informationIdentification and Management of Central Vascular Access Device Complications
Identification and Management of Central Vascular Access Device Complications David Hahn, MD Interventional Radiology NorthShore University HealthSystem Evanston, Illinois Disclosures Consultant, AngioDynamics,
More informationUse of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group
Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationNOTE: Deep Vein Thrombosis (DVT) Risk Factors
Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the
More informationThrombosis: The Other Central Venous Catheter Complication
Thrombosis: The Other Central Venous Catheter Complication The Thrombosis-Infection Relationship Cheryl Kelley RN BSN, VA-BC Sr. Vascular Access Clinical Specialist Disclosure Employed by Teleflex Medical
More informationOsamah Al-Asadi 1,2,3*, Manar Almusarhed 1,2,4 and Hany Eldeeb 1,2
Al-Asadi et al. Thrombosis Journal (2019) 17:2 https://doi.org/10.1186/s12959-019-0191-y REVIEW Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters
More informationA Primer on Central Venous Access: Peripherally-Inserted Central Catheters, Tunneled Catheters, and Subcutaneous Ports
Disclosures A Primer on Central Venous Access: Peripherally-Inserted Central Catheters, Tunneled Catheters, and Subcutaneous Ports No conflicts of interest relevant to this presentation Jason W. Pinchot,
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationThrombosis and Cancer: A Major Complication of Cancer Care
Thrombosis and Cancer: A Major Complication of Cancer Care The close relationship between venous thromboembolism (VTE), malignancy and thrombotic risks/complications of central venous catheters in cancer
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationRISK FACTORS. Cancer type. Cancer stage
CANCER ASSOCIATED THROMBOSIS RISK FACTORS The link between cancer and thrombosis is well established, with malignancy recognised as the most important individual risk factor for venous thromboembolism
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationEpidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione
Epidemiologia e clinica del tromboembolismo venoso Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Thrombophilia may present clinically as one or more of several thrombotic manifestations
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationCanadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC
Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM
More informationPreventing Venous Thromboembolism (VTE)
INTERNET INFORMATION SOURCES North American Thrombosis Forum www.natfonline.org Clot Care www.clotcare.com MANITOUWADGE GENERAL HOSPITAL National Alliance for Thrombosis/Thrombophilia www.stoptheclot.org
More informationDon't place, or leave in place, peripherally inserted central catheters for patient or provider convenience.
Society of General Internal Medicine Choosing Wisely 5 Things Physicians & Patients Should Question April, 2016 Original authors (2013): Vineet Chopra, Laurence McMahon, Jr. Updated by Robert Fogerty,
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationEpidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic
Submassive PE Pulmonary Embolism Epidemiology: Incidence VTE: 100-200/100,000 = 3rd most frequent cardiovascular disease Symptomatic DVT complicated by PE = 40-50% Sudden fatal PE = 34% Intermediate-risk
More informationAnalysis and clinical significance of venography findings in complications associated with peripherally inserted central catheters.
Biomedical Research 2017; 28 (15): 6619-6625 ISSN 0970-938X www.biomedres.info Analysis and clinical significance of venography findings in complications associated with peripherally inserted central catheters.
More informationDeep Vein Thrombosis
Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationVenous Thromboembolism. Prevention
Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and
More informationAggressive endovascular management of ilio-femoral DVT. thrombotic syndrome. is the key in preventing post
CACVS 2017 Aggressive endovascular management of ilio-femoral DVT is the key in preventing post thrombotic syndrome ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HEALTH SYSTEM
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationSlide 1. Slide 2 Disclosures. Slide 3 Learning Objectives. Catheter-Related Thrombosis and Infection: Reducing Controllable Risk Factors
Slide 1 Catheter-Related Thrombosis and Infection: Reducing Controllable Risk Factors Thomas P. Nifong, MD Vice President, Clinical Operations Metamark Genetics, Inc Cambridge, Massachusetts USA Slide
More informationMalfunctioning and Infected Tunneled Infusion Catheters: Over-the-Wire Catheter Exchange versus Catheter Removal and Replacement
CLINICAL STUDY Malfunctioning and Infected Tunneled Infusion Catheters: Over-the-Wire Catheter versus Catheter Removal and David M. Guttmann, BS, Scott O. Trerotola, MD, Timothy W. Clark, MD, Mandeep Dagli,
More informationMy patient. linetm. Help maintain quality care in the pediatric setting
My patient My my linetm linetm Help maintain quality care in the pediatric setting The role of central venous access devices in pediatric patients Central venous access devices (CVADs), also known as central
More informationUnderstanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal
Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria
More informationThe Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections M A R C H 15, 2017
The Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections D A R C Y DOELLMAN M S N, RN, CRNI, VA - BC M A R C H 15, 2017 LOUISVILLE, KENTUCKY Cincinnati Children s Hospital 642
More informationVENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital
More informationPRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES
PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES Mario Mandalà, MD Unit of Clinical Research Department of Oncology and Haematology Papa Giovanni XXIII Hospital Cancer Center
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationEarly Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN
Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,
More informationThe Evidence Base for Treating Acute DVT
The Evidence Base for Treating Acute DVT Mr Chung Sim Lim Consultant Vascular Surgeon and Honorary Lecturer Royal Free London NHS Foundation Trust and University College London NIHR UCLH Biomedical Research
More informationPort Design. Page 1. Port Placement, Removal, and Management. Selecting a Vascular Access Device. Thomas M. Vesely, MD
Non-Dialysis Procedures Port Placement, Removal, and Management Thomas M. Vesely, MD Saint Louis, Missouri Selecting a Vascular Access Device Duration of use Number of lumens Frequency used Blood flow
More informationDeep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients
Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients What is a deep vein thrombosis (DVT)? A DVT is a blood clot that forms within a vein deep in the leg but can
More informationVTE in Children: Practical Issues
VTE in Children: Practical Issues Wasil Jastaniah MBBS,FAAP,FRCPC Consultant Pediatric Hem/Onc/BMT May 2012 Top 10 Reasons Why Pediatric VTE is Different 1. Social, ethical, and legal implications. 2.
More informationAcoustic Pulse Thrombolysis Treatment
Acoustic Pulse Thrombolysis Treatment BTGVascular.com SETTING THE STANDARD FOR VASCULAR THERAPIES Quickly & safely dissolve thrombus with the EKOS System. The Acoustic Pulse Difference Acoustic Pulse Thrombolysis
More informationRisk of Symptomatic DVT Associated With Peripherally Inserted Central Catheters
CHEST Original Research DEEP VEIN THROMBOSIS Risk of Symptomatic DVT Associated With Peripherally Inserted Central Catheters R. Scott Evans, PhD ; Jamie H. Sharp, RN, CNSN ; Lorraine H. Linford, RN, BS,
More informationThe risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
Jones et al. Thrombosis Journal (2017) 15:25 DOI 10.1186/s12959-017-0148-y RESEARCH Open Access The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer
More informationΜακροχρόνια παρακολούθηση ασθενών με πνευμονική εμβολή
Μακροχρόνια παρακολούθηση ασθενών με πνευμονική εμβολή Ευφροσύνη Δ. Μάναλη Λέκτορας Β Πανεπιστημιακή Πνευμονολογική Κλινική ΓΝΑ «Αττικόν» Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών Existing guidelines
More informationBritish Journal of Cancer Research
217 Case Report 2018; 1(4): 217-221. doi: 10.31488/bjcr.119 Peripheral Inserted Central Catheter Associated Bloodstream Infection Concurrent With Upper Extremity Venous Thrombosis : a Case Report Yuejiao
More informationInferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008
Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins
More informationUpper Extremity Venous Duplex. Michigan Sonographers Society Fall Ultrasound Symposium October 15, 2016
Upper Extremity Venous Duplex Michigan Sonographers Society Fall Ultrasound Symposium October 15, 2016 Patricia A. (Tish) Poe, BA RVT FSVU Director of Quality Assurance Navix Diagnostix Patricia A. Poe
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Complications of Central Venous Catheters EPIDEMIOLOGY & DIAGNOSIS & PREVENTION Federico Bozzetti (Italy) CVC COMPLICATIONS EPIDEMIOLOGY & DIAGNOSIS & PREVENTION Federico Bozzetti
More informationBy Daniel H. Ahn, DO, Henrik Bo Illum, MD, David H. Wang, MD, Anant Sharma, MD, and Jonathan E. Dowell, MD
Health Care Delivery Original Contribution Upper Extremity Venous Thrombosis in Patients With Cancer With Peripherally Inserted Central Venous Catheters: A Retrospective Analysis of Risk Factors By Daniel
More informationFrequently Asked Questions about Cancer Associated Thrombosis
+ Frequently Asked Questions about Cancer Associated Thrombosis Atlantic Canada Oncology Group Annual Meeting June 13 th, 2015 Sudeep Shivakumar, Dalhousie University + Conflict of Interest Disclosures
More informationPROGNOSIS AND SURVIVAL
CANCER ASSOCIATED THROMBOSIS PROGNOSIS AND SURVIVAL Since French internist Armand Trousseau reported the occurrence of mysterious thrombotic disorders in cancer patients in the mid-19th century, the link
More informationThe C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions
The C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions page 2 TABLE OF CONTENTS Part 1: Definition and Scope of Catheter Occlusion Part 2: Predictors of Catheter Occlusion Part
More informationIs it Necessary to Verify Blood Return in Monthly Port Flushes?
Is it Necessary to Verify Blood Return in Monthly Port Flushes? Gloria B. Ascoli, RN, CRNI, Amy C. Brown, BSN, RN, Jessica L. Cooper, BSN, RN, Allison N. Crawford, BSN, RN, CRNI Background Research Aims
More informationVenous Thrombo-Embolism (VTE)
Venous Thrombo-Embolism (VTE) Information for service users and carers RDaSH leading the way with care Older People s Mental Health Services Reducing risk of unwanted blood clots whilst in hospital About
More informationPICC, port e trombosi cateterecorrelata: la prevenzione è legata alla tecnica di impianto!
PICC, port e trombosi cateterecorrelata: la prevenzione è legata alla tecnica di impianto! Massimo Lamperti MD, MBA! Clinical Professor of Anesthesiology! Cleveland Clinic Lerner College of Medicine! Chief
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationTreatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice
Treatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice Mert Dumantepe, MD Acibadem Altunizade Hospital, Istanbul, Turkey Department of Cardiovascular Surgery Disclosure
More information1. SCOPE of GUIDELINE:
Page 1 of 35 CLINICAL PRACTICE GUIDELINE: Venous Thromboembolism (VTE) Prevention Guideline: Thromboprophylaxis AUTHORIZATION: VP, Medicine Date Approved: May 17, 2012 Date Revised: Vancouver Coastal Health
More information4/30/2018 CLOT+ In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce t
In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce the rate of post-thrombotic syndrome Question In patients who have symptomatic
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationClinical Study Is There Any Association between PEEP and Upper Extremity DVT?
Critical Care Research and Practice Volume 2015, Article ID 614598, 5 pages http://dx.doi.org/10.1155/2015/614598 Clinical Study Is There Any Association between PEEP and Upper Extremity DVT? Farah Al-Saffar,
More informationCVAD Selection and Tip Placement Overcoming Controversies with Evidence
CVAD Selection and Tip Placement Overcoming Controversies with Evidence Scott O. Trerotola, MD Stanley Baum Professor of Radiology and Surgery Chief, Vascular and Interventional Radiology University of
More informationThe Conservative and Active Management of Post Thrombotic Syndrome
The Conservative and Active Management of Post Thrombotic Syndrome Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guys and St Thomas Hospital London How important
More informationCancer and the Risk of Blood Clots
Patient & Family Guide 2018 Cancer and the Risk of Blood Clots www.nscancercare.ca Table of Contents Terms Used in this Booklet 1 What are Blood Clots? 2 When are Cancer Patients at the Highest Risk for
More informationPrevent Bloodstream Infections by Using Appropriate Devices
37 Prevent Bloodstream Infections by Using Appropriate Devices Situation Catheter-associated infections include exit, tunnel, pocket and bloodstream infections. In the United States, when these types of
More informationInferior Vena Cava Filters
Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal
More informationReducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge
Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein
More informationSuccessful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy. Michael K. W. Lichtenberg
Successful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy Michael K. W. Lichtenberg Disclosure Speaker name: Michael Lichtenberg... I have the following potential conflicts
More informationTHROMBOTIC DISORDERS: The Final Frontier
THROMBOTIC DISORDERS: The Final Frontier Jeffrey I. Weitz, MD, FRCP(C), FACP Professor of Medicine and Biochemistry McMaster University Canada Research Chair in Thrombosis Heart & Stroke Foundation/ J.F.
More information- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes
- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes Michael K. W. Lichtenberg, FESC Conflict of Interest - Disclosure Within
More informationVenous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH
Venous Thrombo-Embolism John de Vos Consultant Haematologist RSCH overview The statistics Pathogenesis Prophylaxis Treatment Agent Duration Incidental VTE Recurrence of VTE IVC filters CVC related thrombosis
More informationPatients with suspected DVT of the lower limb how to exam the patient
Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology
More informationMore than 5 million central venous
The Art and Science of Infusion Nursing Andrew B. Smitherman, MD Brent W. Weston, MD Catheter-Associated Thrombosis in Children Single-Institution Experience and Review of Pediatric Venous Thromboembolic
More informationOverview of CVADs. Type of device commonly used. Dwell time Flushing requirement Associated complications. lumens
Source: Clinical Skills Management of Vascular Access Devices Pre-course handbook. Adapted with permission from NHS Lothian Employee and Education Development Team. Overview of CVADs Type of device Veins
More informationOCCLUSION MANAGEMENT of Central Vascular Access Devices in Adult Patients Competency Test Performance Criteria Checklist References
OCCLUSION MANAGEMENT of Central Vascular Access Devices in Adult Patients Competency Test Performance Criteria Checklist References Score /36 = % Exam adapted from AHS Clinical Policy Occlusion Management
More informationPathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University
Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types
More informationRisk stratification and incidence of acute complications in upper extremity deep vein thrombosis (UEDVT) patients.
Risk stratification and incidence of acute complications in upper extremity deep vein thrombosis (UEDVT) patients. Dr. Santosh Yatam Ganesh MBBS, MPH., Mentors: Dr. Khalid J. Qazi MD, MACP., Dr. Paul Anain
More informationThe Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)
Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or
More informationVTE General Background
VTE General Background VTE incidence is about 1:1000 persons annually >250,000 admissions for VTE annually >100,000 people die of PE annually >90% of PE s arise from lower limb DVT 50% of DVT at diagnosis
More informationCancer and Thrombosis
Cancer and Thrombosis The close relationship between venous thromboembolism and cancer has been known since at least the 19th century by Armand Trousseau. Thrombosis is a major cause of morbidity and mortality
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE
. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 003; 5():-5.. Hamper UM, DeJong MR, Scoutt LM. Ultrasound
More informationCausative factors of deep vein thrombosis of lower limb in Indian population
International Surgery Jthisnal Khadilkar R et al. Int Surg J. 18 Jan;(1):3-3 http://www.ijsurgery.com pissn 39-33 eissn 39-9 Original Research Article DOI: http://dx.doi.org/1.183/39-9.isj17919 Causative
More informationClinical Guide - Inferior Vena Cava Filters (Reviewed 2006)
Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Principal Developer: V. Oliva Secondary Developers: W. Geerts Background The treatment of choice for deep venous thrombosis (DVT) and pulmonary
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationWITH ENDEXO ADVANCED TECHNOLOGY TECHNOLOGY DESIGNED TO IMPROVE ADVANCED TECHNOLOGY SOLUTIONS OUTCOMES* PATIENT OUTCOMES COST EFFECTIVE
WITH ENDEXO TECHNOLOGY ADVANCED TECHNOLOGY ADVANCED TECHNOLOGY SOLUTIONS DESIGNED TO IMPROVE PATIENT OUTCOMES DESIGNED TO IMPROVE OUTCOMES* COST EFFECTIVE ADVANCED TECHNOLOGY DESIGNED TO IMPROVE OUTCOMES*
More informationModerators: Malgorzata Lutwin-Kawalec, MD, Dinesh K Choudhry, MD, FRCA. Institution: Nemours/AI DuPont Hospital for Children, Wilmington, DE
PBLD Table # 17 A teenager with Factor V Leiden and pectus excavatum for a Nuss procedure: navigating recommendations for testing, perioperative risk of thrombosis and post-operative pain management. Moderators:
More informationThrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationCENTRAL VENOUS ACCESS DEVICES. BETHANY COLTON
CENTRAL VENOUS ACCESS DEVICES. BETHANY COLTON Aims and Objectives To know what central venous access devices (CVAD) are. Types of CVADS used in haematology. To understand why we use them To know the complications
More informationRisk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease
Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease Kristen Nelson, MD Johns Hopkins University Director, Pediatric Cardiac Critical Care Why Does it Matter? Pediatric
More informationVenous Thromboembolic Events (VTEs)
Venous Thromboembolic Events (VTEs) This Infosheet explains what a VTE is, what the causes and risk factors for VTEs are, the symptoms of a VTE, how they can be treated and some tips for self-management.
More information